DE2542792A1 - Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern - Google Patents

Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern

Info

Publication number
DE2542792A1
DE2542792A1 DE19752542792 DE2542792A DE2542792A1 DE 2542792 A1 DE2542792 A1 DE 2542792A1 DE 19752542792 DE19752542792 DE 19752542792 DE 2542792 A DE2542792 A DE 2542792A DE 2542792 A1 DE2542792 A1 DE 2542792A1
Authority
DE
Germany
Prior art keywords
milk
tge
virus
calving
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752542792
Other languages
German (de)
English (en)
Inventor
Vipin K Dr Med Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diamond Shamrock Corp
Original Assignee
Diamond Shamrock Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US332405A priority Critical patent/US3911108A/en
Priority to CA192,058A priority patent/CA1027477A/en
Priority to GB37879/75A priority patent/GB1508050A/en
Application filed by Diamond Shamrock Corp filed Critical Diamond Shamrock Corp
Priority to DE19752542792 priority patent/DE2542792A1/de
Priority to FR7530018A priority patent/FR2326204A1/fr
Publication of DE2542792A1 publication Critical patent/DE2542792A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/10—Preservation of milk or milk preparations
    • A23B11/18—Preservation of milk or milk preparations by addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/20—Animal feeding-stuffs from material of animal origin
    • A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
    • A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19752542792 1973-02-14 1975-09-25 Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern Withdrawn DE2542792A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US332405A US3911108A (en) 1973-02-14 1973-02-14 Process of producing bovine milk products containing specific antibodies
CA192,058A CA1027477A (en) 1973-02-14 1974-02-08 Process for producing bovine milk products containing specific antibodies
GB37879/75A GB1508050A (en) 1973-02-14 1975-09-15 Bovine milk products
DE19752542792 DE2542792A1 (de) 1973-02-14 1975-09-25 Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern
FR7530018A FR2326204A1 (fr) 1973-02-14 1975-10-01 Procede pour augmenter, dans le lait de bovides, la quantite d'anticorps specifiques vis-a-vis d'un antigene, produits obtenus par ce procede et leur application en medecine veterinaire

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US332405A US3911108A (en) 1973-02-14 1973-02-14 Process of producing bovine milk products containing specific antibodies
GB37879/75A GB1508050A (en) 1973-02-14 1975-09-15 Bovine milk products
DE19752542792 DE2542792A1 (de) 1973-02-14 1975-09-25 Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern
FR7530018A FR2326204A1 (fr) 1973-02-14 1975-10-01 Procede pour augmenter, dans le lait de bovides, la quantite d'anticorps specifiques vis-a-vis d'un antigene, produits obtenus par ce procede et leur application en medecine veterinaire

Publications (1)

Publication Number Publication Date
DE2542792A1 true DE2542792A1 (de) 1977-04-07

Family

ID=27432029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752542792 Withdrawn DE2542792A1 (de) 1973-02-14 1975-09-25 Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern

Country Status (5)

Country Link
US (1) US3911108A (enExample)
CA (1) CA1027477A (enExample)
DE (1) DE2542792A1 (enExample)
FR (1) FR2326204A1 (enExample)
GB (1) GB1508050A (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
IE50254B1 (en) * 1979-11-13 1986-03-05 Univ Iowa State Res Found Inc Vaccine and process for its preparation
US4402938A (en) * 1980-05-29 1983-09-06 Impro Products, Inc. Food and the method of extracting the same from colostrum and milk
JPS5742629A (en) * 1980-08-29 1982-03-10 Sendai Biseibutsu Kenkyusho Remedy for refractory diseases
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
USRE33403E (en) * 1982-06-03 1990-10-23 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4705748A (en) * 1983-07-21 1987-11-10 Idaho Research Foundation, Inc. Antigen associated with early detection of mammalian pregnancy
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same
US4834974A (en) * 1986-01-13 1989-05-30 Protein Technologies, Inc. Immunologically active whey fraction and recovery process
US4816252A (en) * 1985-04-15 1989-03-28 Protein Technology, Inc. Product and process for transferring passive immunity to newborn domestic animals using ultrafiltered whey containing immunoglobulins
US5198213A (en) * 1985-04-15 1993-03-30 Protein Technology, Inc. Method of disease treatment utilizing an immunologically whey fraction
US4843065A (en) * 1985-05-22 1989-06-27 Collins Robert A Method of producing products for use in the treatment of bacterial and/or virus infections
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
WO1992002538A1 (en) * 1990-07-30 1992-02-20 Procor Technologies, Inc. Product and method for transfer of colostrum-derived disease preventing constituents across the gastrointestinal tract
DE4026365A1 (de) 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
CA2177060A1 (en) * 1993-12-21 1995-06-29 Philip J. Provost Thermostable varicella zoster virus
US5922344A (en) * 1995-02-10 1999-07-13 Abbott Laboratories Product for prevention of respiratory virus infection and method of use
US5670196A (en) * 1995-04-12 1997-09-23 Galagen Inc. Method for microfiltration of milk or colostral whey
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
WO1997002839A1 (en) * 1995-07-13 1997-01-30 Gkc Research, Inc. Viral suppression, treatment and prevention of viral infections
FI110752B (fi) 1999-05-25 2003-03-31 Novatreat Oy Menetelmä ternimaidon käsittelemiseksi
US20050175597A1 (en) * 2002-03-21 2005-08-11 Rawlin Grant T. Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
CA2486801A1 (en) * 2002-05-21 2003-11-27 Anadis Ltd Method of prophylaxis of infection
DK2061510T3 (en) * 2006-08-31 2016-09-05 A C N 135 493 391 Pty Ltd As Trustee For Conca Unit Trust Treatment and / or prevention of Barrett's esophagus using anti-EphB4 antibody-containing compositions
US8475789B2 (en) * 2008-01-22 2013-07-02 Multimerics Aps Products and methods to prevent infections
NL2004099C2 (en) * 2010-01-15 2011-07-18 Friesland Brands Bv Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof.
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients
WO2022148549A1 (en) 2020-01-14 2022-07-14 Babylat Gmbh Apparatus and method for obtaining protein-enriched fractions from breast milk

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2705696A (en) * 1951-03-30 1955-04-05 American Cyanamid Co Production of antigens
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk

Also Published As

Publication number Publication date
GB1508050A (en) 1978-04-19
US3911108A (en) 1975-10-07
FR2326204A1 (fr) 1977-04-29
FR2326204B1 (enExample) 1979-10-12
CA1027477A (en) 1978-03-07

Similar Documents

Publication Publication Date Title
DE2542792A1 (de) Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern
DE3504221C2 (de) Mittel zur passiven Immunisierung von Säugern
DE3689717T2 (de) Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
US3376198A (en) Method of producing antibodies in milk
DE69722217T2 (de) Verewndung von hyperimmunisierte milch und/oder ei zur behandlung von magen-darm verletzungen
DE3882599T2 (de) Hundecoronavirus-Impfstoff.
DE69636001T2 (de) Multikomponentimpfstoff aus niedrigdosierten Clostridien und Nicht-Clostridien-Organismen
DE69333588T2 (de) Verfahren zur verstärkung zellularer immunantworten
DE2360118B2 (de) Impfstoff gegen Ferkel-Colibacillose
US3423505A (en) Rabies vaccine and process for preparation thereof
CA1136043A (en) Vaccines against diseases, caused by reo-virus, and process for the preparation of those vaccines
DE2057544C3 (de) Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
DE833673C (de) Verfahren zur Herstellung einer Schweinecholera-Lymphe
WO2000052055A1 (de) SPEZIFISCHE IgY-EIDOTTERANTIKÖRPER, IHRE GEWINNUNG UND IHRE VERWENDUNG
DE3136430C2 (enExample)
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
DE2700338C2 (de) Parenteral injizierbarer Impfstoff für Schweine gegen Infektionen von Bordetella bronchiseptica sowie Verfahren zum Herstellen dieses Impfstoffes
DE2126957A1 (de) Impfstoff gegen Gänsehepatitis
DE2045160B2 (de) Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner
DE1235505B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE2728806A1 (de) Auf oralem wege einzunehmender antiparasitaerer impfstoff, verfahren zu dessen herstellung und anwendungsmethode des impfstoffs bei saeugetieren
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits
DE2842260A1 (de) Vakzinepraeparat zur prophylaxe und behandlung von klostridiosen bei vieh und gefluegel
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
AT300193B (de) Verfahren zur Herstellung von Mastitis-Immunoglobulin

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee